Ranbaxy Laboratories
Latest Ranbaxy Laboratories News
-
Senators Pan Pfizer’s Plan to Block Generic Lipitor
Wednesday, the U.S. Food and Drug Administration approved the first generic version of Lipitor, made by Ranbaxy Laboratories Ltd . Ranbaxy has exclusive rights to sell the generic for 180 days, during which time it will be Lipitor’s sole competitor
-
Consumers Will Pay Half as Much for Generic Version of Lipitorconsumers who want to switch to the generic right away. Ranbaxy Laboratories , the manufacturer with exclusive rights to sell atorvastatin total of nearly $1 billion. After the next 180 days, Ranbaxy 's exclusive rights to sell the generic drug will
-
Lipitor Among Top Drugs Coming Off Patentmanaged to hold off competition until later this year. Ranbaxy , an India-based pharmaceutical company, agreed to delay of Lipitor until Nov. 30. According to its website, Ranbaxy will have the exclusive right to sell its drug in the U
-
Health Highlights: May 5, 2009
release, UPI reported. ----- Ranbaxy Announces U.S. Recall of Antibiotic announced by India-based drug maker Ranbaxy . The recall of 100-milligram capsules said a statement released by Ranbaxy , which gave no details about the
-
Health Highlights: May 4, 2009
compiled by editors of HealthDay: Ranbaxy Announces U.S. Recall of Antibiotic announced by India-based drug maker Ranbaxy . The recall of 100-milligram capsules said a statement released by Ranbaxy , which gave no details about the
-
FDA Halts New Applications From Indian Drug Maker's Plant
any new drug applications from a Ranbaxy Laboratories plant in India after determining was falsifying scientific data. Ranbaxy , based in India, is one of the less than six months. "No other Ranbaxy facilities are directly affected
News
-
Health Highlights: Oct. 22, 2008
continues its investigation of the agency's handling of problems at two Indian plants run by generic drug maker Ranbaxy Laboratories . In September, the FDA banned import of 30 generic drugs produced at the two plants. The action came several
-
FDA Bars Generic Drugs From Indian Company
drugs made by Indian drug maker Ranbaxy Laboratories Ltd . are being denied entry into the Administration announced Tuesday. Ranbaxy is one of the world's largest meet consumer demand. However, Ranbaxy is the sole U.S. supplier of
-
As Seen On TV: FDA Generic Drug Import Ban
widely used generic drugs made by Ranbaxy Laboratories Ltd ., a major manufacturer in India generic drugs produced at two of Ranbaxy 's plants. People taking any of amounts, produced at two of Ranbaxy 's facilities. Click here to
-
FDA Bans Import of Meds From Major Drug MakerAlavert and Claritin, all made at two Ranbaxy plants in India, could be affected Evaluation and Research. Based in India, Ranbaxy has already been under investigation offices in New Jersey. Last year, Ranbaxy recalled 73 million doses of a generic
-
Feds Allege Ranbaxy Lied About Quality of Drugs
that Indian generic drugmaker Ranbaxy Laboratories deliberately misled the U.S Justice Department is demanding Ranbaxy turn over documents which it hopes filing asks the court to order Ranbaxy to turn over the documents. Ranbaxy
-
Health Highlights: June 18, 2008
reached between Pfizer Inc. and Ranbaxy Laboratories Ltd . of India. "The agreement provides generic product much earlier than if Ranbaxy were unsuccessful in obtaining market. The deal also permits Ranbaxy to sell generic versions of Lipitor
-
Health Highlights: Feb. 13, 2008
2009. The patches were also sold in Canada under the Duragesic brand by Janssen-Ortho Inc. and generically by Ranbaxy Laboratories Ltd ., the AP said. A total of about 32 million patches will be recalled. PriCara estimates that two patches per
Videos
-
FDA Bans Generic Indian DrugsImports of more than 30 drugs made by Ranbaxy Laboratories are being blocked.
